Pharvaris N.V.
PHVS
$35.14
$1.103.23%
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | 0.62% | 11.11% | 11.11% | 29.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 21.92% | 33.16% | 33.16% | 43.36% |
| Operating Income | -- | -21.92% | -33.16% | -33.16% | -43.36% |
| Income Before Tax | -- | -36.67% | -26.12% | -26.12% | -48.49% |
| Income Tax Expenses | -- | 16.03% | 14.81% | 14.81% | 57.26% |
| Earnings from Continuing Operations | -- | -36.39% | -26.01% | -26.01% | -48.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -36.39% | -26.01% | -26.01% | -48.59% |
| EBIT | -- | -21.92% | -33.16% | -33.16% | -43.36% |
| EBITDA | -- | -21.88% | -33.22% | -33.12% | -43.38% |
| EPS Basic | -- | -25.37% | -14.73% | -14.73% | -30.34% |
| Normalized Basic EPS | -- | -25.71% | -14.86% | -14.86% | -30.30% |
| EPS Diluted | -- | -25.37% | -14.73% | -14.73% | -30.34% |
| Normalized Diluted EPS | -- | -25.71% | -14.86% | -14.86% | -30.30% |
| Average Basic Shares Outstanding | -- | 9.47% | 9.61% | 9.61% | 12.85% |
| Average Diluted Shares Outstanding | -- | 9.47% | 9.61% | 9.61% | 12.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |